myopathy, reducing body, X-linked, early-onset, severe

Rare Disease

MONDO:0010414

Also known as:

myopathy, reducing body, X-linked, early-onset, severereducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, X-linked dominantRBMX1A

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Companies Active in myopathy, reducing body, X-linked, early-onset, severe

0 approved

Organizations with approved therapies for this disease

No approved therapies yet

Research is ongoing — 2 companies have orphan drug designations for this disease

AbbVie Inc.

Other

Designated

Serono, Inc.

Other

Designated

View all companies active in myopathy, reducing body, X-linked, early-onset, severe

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases